This company has been marked as potentially delisted and may not be actively trading. Amedisys (AMED) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsBuy This Stock Get the Latest News and Ratings for AMED and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Amedisys and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMED Analyst Ratings Over TimeTypeCurrent Forecast9/18/24 to 9/18/251 Month Ago8/19/24 to 8/19/253 Months Ago6/20/24 to 6/20/251 Year Ago9/19/23 to 9/18/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy1 Buy rating(s)1 Buy rating(s)1 Buy rating(s)1 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)4 Hold rating(s)4 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$100.50$100.50$100.75$100.67Forecasted Upside-0.50% Downside-0.50% Downside3.38% Upside3.62% UpsideConsensus RatingModerate BuyModerate BuyHoldHold AMED Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History AMED Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Amedisys Stock vs. The CompetitionTypeAmedisysMedical CompaniesS&P 500Consensus Rating Score 2.50 2.78 2.53Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside-0.50% Downside14,578.04% Upside10.91% UpsideNews Sentiment RatingNeutral NewsSee Recent AMED NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails4/16/2025Royal Bank Of Canada3 of 5 starsBen Hendrix Not RatedReiterated RatingOutperform$100.00 ➝ $100.00+8.94%3/4/2025Stephens4 of 5 starsScott Fidel Not RatedReiterated RatingEqual Weight$101.00 ➝ $101.00+9.78%7/29/2024Deutsche Bank Aktiengesellschaft2 of 5 stars DowngradeBuy ➝ Hold$101.00 ➝ $101.00+2.80%7/25/2024Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingNeutral$101.00 ➝ $101.00+3.06%7/1/2024William BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingM. LarewSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOutperform ➝ Market Perform3/26/2024Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingMarket PerformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:27 PM ET. AMED Forecast - Frequently Asked Questions What is Amedisys' forecast for 2025? According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Amedisys is $100.50, with a high forecast of $101.00 and a low forecast of $100.00. Should I buy or sell Amedisys stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Amedisys in the last year. There is currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AMED shares. Does Amedisys's stock price have much downside? According to analysts, Amedisys's stock has a predicted downside of -0.50% based on their 12-month stock forecasts. Do Wall Street analysts like Amedisys more than its competitors? Analysts like Amedisys less than other "medical" companies. The consensus rating score for Amedisys is 2.50 while the average consensus rating score for "medical" companies is 2.78. Learn more on how AMED compares to other companies. Stock Forecasts and Research Tools Related Companies DaVita Stock Forecast Chemed Stock Forecast Pediatrix Medical Group Stock Forecast AMN Healthcare Services Stock Forecast Cross Country Healthcare Stock Forecast Labcorp Stock Forecast Quest Diagnostics Stock Forecast Encompass Health Stock Forecast Elanco Animal Health Stock Forecast RadNet Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:AMED) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedisys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedisys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMED Stock Alerts